STRS Ohio’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$567K Hold
62,200
﹤0.01% 1181
2025
Q1
$494K Buy
+62,200
New +$494K ﹤0.01% 1189
2024
Q1
Sell
-7,300
Closed -$158K 2022
2023
Q4
$158K Hold
7,300
﹤0.01% 1625
2023
Q3
$150K Hold
7,300
﹤0.01% 1642
2023
Q2
$343K Buy
+7,300
New +$343K ﹤0.01% 1429
2022
Q4
Sell
-4,700
Closed -$184K 2055
2022
Q3
$184K Sell
4,700
-3,200
-41% -$125K ﹤0.01% 1622
2022
Q2
$255K Buy
+7,900
New +$255K ﹤0.01% 1530
2021
Q3
Sell
-23,093
Closed -$1.31M 2309
2021
Q2
$1.31M Buy
23,093
+12,050
+109% +$684K ﹤0.01% 999
2021
Q1
$826K Buy
+11,043
New +$826K ﹤0.01% 1297
2020
Q1
Sell
-52,000
Closed -$3.75M 2082
2019
Q4
$3.75M Sell
52,000
-27,642
-35% -$2M 0.02% 528
2019
Q3
$11.2M Sell
79,642
-42,901
-35% -$6.02M 0.05% 346
2019
Q2
$22.4M Sell
122,543
-76,957
-39% -$14.1M 0.1% 252
2019
Q1
$31.7M Sell
199,500
-30,500
-13% -$4.85M 0.14% 189
2018
Q4
$22M Buy
230,000
+87,583
+61% +$8.39M 0.11% 237
2018
Q3
$20.1M Buy
142,417
+121,206
+571% +$17.1M 0.09% 272
2018
Q2
$3.32M Sell
21,211
-9,289
-30% -$1.45M 0.01% 561
2018
Q1
$4.91M Buy
30,500
+1,900
+7% +$306K 0.02% 467
2017
Q4
$4.71M Sell
28,600
-41,300
-59% -$6.8M 0.02% 492
2017
Q3
$4.35M Buy
69,900
+15,600
+29% +$972K 0.02% 509
2017
Q2
$4.32M Sell
54,300
-49,300
-48% -$3.93M 0.02% 507
2017
Q1
$7.36M Buy
103,600
+200
+0.2% +$14.2K 0.03% 433
2016
Q4
$5.28M Buy
103,400
+5,900
+6% +$301K 0.02% 494
2016
Q3
$4.49M Buy
+97,500
New +$4.49M 0.02% 516
2016
Q2
Sell
-7,400
Closed -$237K 2026
2016
Q1
$237K Sell
7,400
-5,600
-43% -$179K ﹤0.01% 1477
2015
Q4
$757K Hold
13,000
﹤0.01% 973
2015
Q3
$550K Hold
13,000
﹤0.01% 1235
2015
Q2
$949K Buy
+13,000
New +$949K ﹤0.01% 889
2015
Q1
Sell
-2,000
Closed -$73K 1856
2014
Q4
$73K Hold
2,000
﹤0.01% 1576
2014
Q3
$63K Buy
+2,000
New +$63K ﹤0.01% 1620